187 related articles for article (PubMed ID: 36983821)
1. Thirty-Days versus Longer Duration of Dual Antiplatelet Treatment after Percutaneous Coronary Interventions with Newer Drug-Eluting Stents: A Systematic Review and Meta-Analysis.
Tsigkas G; Apostolos A; Chlorogiannis DD; Bousoula E; Vasilagkos G; Tsalamandris S; Tsiafoutis I; Katsanos K; Toutouzas K; Aminian A; Alexopoulos D; Davlouros P
Life (Basel); 2023 Feb; 13(3):. PubMed ID: 36983821
[TBL] [Abstract][Full Text] [Related]
2. Very Short Versus Longer Dual Antiplatelet Treatment After Coronary Interventions: A Systematic Review and Meta-analysis.
Tsigkas G; Apostolos A; Trigka A; Chlorogiannis D; Katsanos K; Toutouzas K; Alexopoulos D; Brilakis ES; Davlouros P
Am J Cardiovasc Drugs; 2023 Jan; 23(1):35-46. PubMed ID: 36536171
[TBL] [Abstract][Full Text] [Related]
3. The optimal discontinuation of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention with drug-eluting stents: A meta-analysis of randomized trials.
Wang W; Liu J; Fang J; Liu Y; An T; Zou M; Cheng G
Int J Cardiol; 2017 May; 235():73-86. PubMed ID: 28284499
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of short-term (1 to 3 months) dual antiplatelet therapy in patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials.
Kheiri B; Simpson TF; Osman M; Golwala H; Radaideh Q; Kumar K; Rahmouni H; Divanji P; Cigarroa JE; Zahr F
J Thromb Thrombolysis; 2020 Nov; 50(4):867-873. PubMed ID: 32607653
[TBL] [Abstract][Full Text] [Related]
5. Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trial.
Ge Z; Gao XF; Kan J; Kong XQ; Zuo GF; Ye F; Tian NL; Lin S; Liu ZZ; Shao YB; He YQ; Wen SY; Yang Q; Xia Y; Wang ZZ; Xiao PX; Li F; Zeng HS; Yang S; Wang Y; Tao L; Gao DS; Qu H; Qian XS; Han YL; Chen F; Zhang JJ; Chen SL
Am Heart J; 2021 Jun; 236():49-58. PubMed ID: 33621541
[TBL] [Abstract][Full Text] [Related]
6. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Bittl JA; Baber U; Bradley SM; Wijeysundera DN
J Am Coll Cardiol; 2016 Sep; 68(10):1116-39. PubMed ID: 27036919
[TBL] [Abstract][Full Text] [Related]
7. Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials.
Giacoppo D; Matsuda Y; Fovino LN; D'Amico G; Gargiulo G; Byrne RA; Capodanno D; Valgimigli M; Mehran R; Tarantini G
Eur Heart J; 2021 Jan; 42(4):308-319. PubMed ID: 33284979
[TBL] [Abstract][Full Text] [Related]
8. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
; Bittl JA; Baber U; Bradley SM; Wijeysundera DN
Circulation; 2016 Sep; 134(10):e156-78. PubMed ID: 27026019
[TBL] [Abstract][Full Text] [Related]
9. Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Sharma A; Garg A; Elmariah S; Drachman D; Obiagwu C; Vallakati A; Sharma SK; Lavie CJ; Mukherjee D; Waksman R; Stefanini GG; Feres F; Marmur JD; Helft G
Prog Cardiovasc Dis; 2018; 60(4-5):500-507. PubMed ID: 29277295
[TBL] [Abstract][Full Text] [Related]
10. [Meta-analysis on safety and efficacy of dual antiplatelet therapy combining with proton pump inhibitors for patients after percutaneous coronary intervention].
Che QQ; Wu Q; Liang YB; Sun RM; Lyu QW; Ma JL; Hu H; Lin X; Xu GL; Sun SG; Zhang C; Wang QY; Yu J; Bai F
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):129-140. PubMed ID: 30818941
[No Abstract] [Full Text] [Related]
11. Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis.
Yin SH; Xu P; Wang B; Lu Y; Wu QY; Zhou ML; Wu JR; Cai JJ; Sun X; Yuan H
BMJ; 2019 Jun; 365():l2222. PubMed ID: 31253632
[TBL] [Abstract][Full Text] [Related]
12. Benefits of short-term or prolonged as compared to standard 1 year DAPT in patients with acute coronary syndrome treated with drug-eluting stents: a meta-analysis of 9 randomized trials.
Verdoia M; Kedhi E; Suryapranata H; Frati G; Biondi-Zoccai G; De Luca G
J Thromb Thrombolysis; 2020 Aug; 50(2):337-354. PubMed ID: 31919736
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Thirty-Day Dual-Antiplatelet Therapy Following Complex Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
Apostolos A; Chlorogiannis DD; Chrysostomidis G; Bozika M; Timpilis F; Kramvis A; Karamasis GV; Leventopoulos G; Davlouros P; Tsigkas G
J Cardiovasc Dev Dis; 2024 Jan; 11(2):. PubMed ID: 38392257
[TBL] [Abstract][Full Text] [Related]
14. Non-inferiority of 1 month
Bajraktari G; Bytyçi I; Bajraktari A; Henein MY
Ther Adv Chronic Dis; 2022; 13():20406223221093758. PubMed ID: 35602665
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Ultra Short-duration Dual Antiplatelet Therapy After Percutaneous Coronary Interventions: A Meta-analysis of Randomized Controlled Trials.
Abusnina W; Baral N; Seri A; Ben-Dor I; Alkhouli M; Monteleone P; Haddad E; Goldsweig AM; Paul TK
Curr Probl Cardiol; 2022 Oct; 47(10):101295. PubMed ID: 35760148
[TBL] [Abstract][Full Text] [Related]
16. 6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin: Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel).
Didier R; Morice MC; Barragan P; Noryani AAL; Noor HA; Majwal T; Hovasse T; Castellant P; Schneeberger M; Maillard L; Bressolette E; Wojcik J; Delarche N; Blanchard D; Jouve B; Ormezzano O; Paganelli F; Levy G; Sainsous J; Carrie D; Furber A; Berlan J; Darremont O; Le Breton H; Lyuycx-Bore A; Gommeaux A; Cassat C; Kermarrec A; Cazaux P; Druelles P; Dauphin R; Armengaud J; Dupouy P; Champagnac D; Ohlmann P; Ben Amer H; Kiss RG; Ungi I; Gilard M
JACC Cardiovasc Interv; 2017 Jun; 10(12):1202-1210. PubMed ID: 28641840
[TBL] [Abstract][Full Text] [Related]
17. Optimal Duration of Dual Antiplatelet Therapy after Drug-Eluting Stents: Meta-Analysis of Randomized Trials.
Abo-Salem E; Alsidawi S; Jamali H; Effat M; Helmy T
Cardiovasc Ther; 2015 Oct; 33(5):253-63. PubMed ID: 26010419
[TBL] [Abstract][Full Text] [Related]
18. Drug-Eluting Versus Bare-Metal Stents in Older Patients: A Meta-Analysis of Randomized Controlled Trials.
Kheiri B; Osman M; Abdalla A; Haykal T; Chahine A; Gwinn M; Ahmed S; Hassan M; Bachuwa G; Bhatt DL
Cardiovasc Revasc Med; 2019 Sep; 20(9):744-751. PubMed ID: 30446398
[TBL] [Abstract][Full Text] [Related]
19. Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials.
Benenati S; Galli M; De Marzo V; Pescetelli F; Toma M; Andreotti F; Della Bona R; Canepa M; Ameri P; Crea F; Porto I
Eur Heart J Cardiovasc Pharmacother; 2021 Mar; 7(2):86-93. PubMed ID: 31942965
[TBL] [Abstract][Full Text] [Related]
20. Short-term vs long-term dual antiplatelet therapy after drug-eluting stent implantation in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis.
Li J; He K; Ge J; Li C; Jing Z
Int J Clin Pract; 2021 Jul; 75(7):e13938. PubMed ID: 33341109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
